Helmut Löffler

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

Susanne Schnittger, Claudia Schoch, Martin Dugas et al. · Blood · 2002 · 964 citations · Full text

Medicine, Hematology, Oncology +17

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann et al. · PubMed · 1999 · 321 citations

Medicine, Oncology, Pharmacology +17

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Wolfgang Kern, Torsten Haferlach, Claudia Schoch et al. · Blood · 2002 · 284 citations · Full text

Medicine, Hematology, Oncology +10

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

Torsten Haferlach, Claudia Schoch, Helmut Löffler et al. · Journal of Clinical Oncology · 2003 · 191 citations

Medicine, Hematology, Oncology +17

Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.

Wolfgang Ludwig, Harald Rieder, Claus R. Bartram et al. · PubMed · 1998 · 190 citations

Medicine, Hematology, Oncology +16